scholarly article | Q13442814 |
P2093 | author name string | Tomohiko Kizaki | |
Noriyuki Ohara | |||
Yojiro Ojima | |||
Saki Sato | |||
Masatoshi Kanda | |||
P2860 | cites work | CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms | Q28214966 |
The management of patients with uterine sarcoma: a debated clinical challenge | Q28241312 | ||
An immunohistochemical study of normal endometrial stroma and endometrial stromal neoplasms. Evidence for smooth muscle differentiation | Q30442473 | ||
Mixed low grade and high grade endometrial stromal sarcoma of uterus: differences on immunohistochemistry and chromosome in situ hybridisation. | Q37219279 | ||
Endometrial stromal sarcoma--the new genetic paradigm | Q38263798 | ||
Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study | Q38735580 | ||
Transition from low-grade endometrial stromal sarcoma to high-grade endometrial stromal sarcoma | Q43773373 | ||
Primary uterine endometrial stromal neoplasms. A clinicopathologic study of 117 cases. | Q43828742 | ||
Expression of progesterone receptor A and B isoforms in low-grade endometrial stromal sarcoma | Q44845076 | ||
Treatment of uterine sarcomas. | Q45939878 | ||
Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. | Q46320562 | ||
Utility of CD10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases | Q46457056 | ||
Transition of endometrial stromal sarcoma into high-grade sarcoma. | Q53342795 | ||
Diagnostic use of nuclear beta-catenin expression for the assessment of endometrial stromal tumors. | Q54539761 | ||
Transition of low-grade to high-grade endometrial stromal sarcoma: a case report | Q57114213 | ||
Endometrial stromal sarcomas | Q67652566 | ||
High-grade pelvic sarcoma after radiation therapy for low-grade endometrial stromal sarcoma | Q68738536 | ||
Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors | Q72852561 | ||
h-Caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma | Q73435852 | ||
h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors | Q73637853 | ||
CD10 is a marker for normal and neoplastic endometrial stromal cells | Q77462405 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endometrial polyp | Q3083434 |
endometrial stromal sarcoma | Q5376363 | ||
stromal sarcoma | Q18975783 | ||
P304 | page(s) | E36-E42 | |
P577 | publication date | 2018-09-11 | |
P1433 | published in | Kobe Journal of Medical Sciences | Q15755362 |
P1476 | title | Endometrial Stromal Sarcoma Arising from Endometrial Polyp: A Case Report | |
P478 | volume | 64 |
Q61443534 | Metastatic low-grade endometrial stromal sarcoma with sex cord and smooth muscle differentiation: A case report | cites work | P2860 |
Search more.